MARKET

ENZ

ENZ

Enzo Biochem Inc
NYSE
1.220
-0.020
-1.61%
Closed 16:02 12/06 EST
OPEN
1.220
PREV CLOSE
1.240
HIGH
1.280
LOW
1.220
VOLUME
82.16K
TURNOVER
0
52 WEEK HIGH
2.740
52 WEEK LOW
1.000
MARKET CAP
61.60M
P/E (TTM)
2.956
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ENZ last week (1127-1201)?
Weekly Report · 3d ago
Enzo Biochem Inc: [Amend]Annual Report
Press release · 11/28 23:05
Weekly Report: what happened at ENZ last week (1120-1124)?
Weekly Report · 11/27 09:29
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Silo pharma shares increased by 36.2% to $2.22 during tuesday's pre-market session. Tracon pharma (nasdaq:tcon) shares rose by 30.02%. Fresh2 group (nasdaq:fres) shares also increased. Losers include morphosys and alzamend neuro.
Benzinga · 11/21 13:06
Weekly Report: what happened at ENZ last week (1113-1117)?
Weekly Report · 11/20 09:29
Weekly Report: what happened at ENZ last week (1106-1110)?
Weekly Report · 11/13 09:28
Jackson Peak Capital Q3 2023  Update
Jackson peak capital manages a single, concentrated, long / short equity portfolio. In q3 2023, jackson peak returned +11.8% despite a tough quarter for overall markets. The portfolio's net exposure was reduced in anticipation of a surge in long-term interest rates.
Seeking Alpha · 11/11 07:30
Enzo Biochem GAAP EPS of $0.41
Enzo biochem reports fy gaap eps of $0.41 and cash and cash equivalents of $83.4 million. the company posted a net loss of $2.2 million in the third quarter. enzo has a market capitalization of $1.2 billion.
Seeking Alpha · 11/06 18:36
More
About ENZ
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

Webull offers Enzo Biochem Inc stock information, including NYSE: ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.